doi: 10.1016/s0022-5347(17)59670-6.
Estrogen-induced hypernephroma
- PMID: 4843321
- DOI: 10.1016/s0022-5347(17)59670-6
Item in Clipboard
Estrogen-induced hypernephroma
J Urol.
1974 Aug.
No abstract available
Similar articles
-
Bilateral breast metastases from oat-cell lung carcinoma in a man treated with diethylstilbestrol for prostatic adenocarcinoma.J Am Geriatr Soc. 1976 Nov;24(11):511-5. doi: 10.1111/j.1532-5415.1976.tb03274.x. J Am Geriatr Soc. 1976. PMID: 184140 No abstract available.
-
Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate.Urology. 1974 Oct;4(4):431-4. doi: 10.1016/0090-4295(74)90013-2. Urology. 1974. PMID: 4423432 No abstract available.
-
Stilphostrol therapy in 100 cases of prostatic carcinoma.J Iowa Med Soc. 1969 Dec;59(12):1096-8. J Iowa Med Soc. 1969. PMID: 4187802 No abstract available.
-
Diethylstilbestrol therapy gynecomastia.JAMA. 1970 Jul 20;213(3):468. JAMA. 1970. PMID: 5468028 No abstract available.
-
[Severe acute thrombosis induced by high dosage of estrogen therapy].Nouv Presse Med. 1978 Jul 1-8;7(27):2396. Nouv Presse Med. 1978. PMID: 673816 French. No abstract available.
Cited by
-
Association of hepatocellular carcinoma and a hyperplastic nodule after phosphate diethylstilbestrol therapy.Gastroenterol Jpn. 1990 Apr;25(2):253-7. doi: 10.1007/BF02776825. Gastroenterol Jpn. 1990. PMID: 2161376
-
Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors.Cancer Causes Control. 1992 Jul;3(4):323-31. doi: 10.1007/BF00146885. Cancer Causes Control. 1992. PMID: 1617119
-
Risk factors for renal cell carcinoma: results of a population-based case-control study.Cancer Causes Control. 1993 Mar;4(2):101-10. doi: 10.1007/BF00053150. Cancer Causes Control. 1993. PMID: 8481488
MeSH terms
Substances
LinkOut - more resources
Full Text Sources